Abstract
Summary. Phlebosclerosis is a venous wall degenerative disease which has gained little popularity in the literature due to its uncertain clinical significance. The objective of this review is to evaluate the epidemiology, etiology and clinical significance of phlebosclerosis in lower extremities veins, particularly the effect of preexisting phlebosclerosis of the great saphenous vein on vein graft patency. Medline was searched from inception until November 1, 2019. Reference lists of included studies were scanned. Only articles published after 1949 were included. Two reviewers independently screened titles/abstracts and full-text papers for any study design in relation to phlebosclerosis in lower extremities veins and abstracted data. A total of 16 Cohort studies and one case-control study (3708 participants, mean age 61.8 years, 59.3 % men, and 40.7 % women) were included after screening 317 titles and abstracts, and 80 full-text articles. The incidence of phlebosclerosis ranged from 1.5–9.7 % depending on the radiological features. On the contrary, the incidence of the phlebosclerotic great saphenous vein prior to its use as a vein graft was 26.9–91 % on histological examination. The small saphenous vein was the most common location of phlebosclerosis followed by the great saphenous vein. There is a link between phlebosclerosis and age, venous insufficiency and haemodialysis. As for the vein graft patency seven studies demonstrated a correlation between preexisting phlebosclerosis and vein graft stenosis, whereas three studies failed to prove any association. In conclusion, the radiological incidence of phlebosclerosis depended on the ultrasound findings. Its presence in the great saphenous vein prior to its use as a vein graft is established on histological examination. The small saphenous vein is mainly affected. Risk factors included age, haemodialysis, and venous insufficiency. Preexisting wall thickness of the great saphenous vein graft seemed to affect negatively its patency in bypass surgery.
References
1 . Phlebosclerosis: disorder or disease? Vasa. 1991;20(3):230–36.
2 . Morphology of intimal hyperplasia. J Vasc Surg. 1989;10:591–92.
3 . Endophlebohypertrophy and phlebosclerosis. I. The poplitean vein. AMA. Arch Pathol. 1951;51:154–78.
4 . Diffuse phlebosclerosis with calcification. Br Med J. 1953;1:80–81.
5 . Endophlebohypertrophy and phlebosclerosis. II. The external and common iliac veins. Am J Pathol. 1952;28:401–11.
6 . Studies in phlebosclerosis: IV. Phlebosclerosis of the pulmonary veins. Am J Cardiol. 1962;10:836–39.
7 . Studies in phlebosclerosis: VI. The immunity from phlebosclerosis in the coronary vein. Am J Cardiol. 1964;13:45–97.
8 . Phlebosclerosis in lower extremities veins. Phlebology. 2014;29:186–90.
9 . The PRISMA statement for reporting systematic review and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.
10 . Pre-bypass quality assessment of the long saphenous vein wall with ultrasound and Histology. Eur J Vasc Endovasc Surg. 1997;14:37–40.
11 Histological survey of the saphenous vein before its use as autologous aortocoronary bypass graft. Thorax. 1980;35:519–22.
12 . The structural study of the saphenous vein. Ann Thorac Surg. 1975;20:636–45.
13 . Pre-bypass morphological changes in vein grafts. Eur J Vasc Surg. 1993;7:642–47.
14 . Remnant saphenous veins after aortocoronary bypass grafting: analysis of 3394 centimeters of unused vein from 402 patients. Am J Cardiol. 1985;55:65–71.
15 . Histological appearances of the long saphenous vein. J Pathol. 1989;159:311–16.
16 . Saphenous vein wall thickness in age and venous reflux associated remodeling in adults. J Vasc Surg Venous Lymphat Disord. 2017;5(2):216–23.
17 . Venous intima-media thickness increases both in deep and superficial systems in patients with great saphenous vein reflux. J Vasc Surg Venous Lymphat Disord. 2019;7(6):832–38.
18 . Significance of phlebosclerosis in Non-healing ischemic foot ulcers of end stage renal disease. Eur J Vasc Endovasc Surg. 2008;36:346–52.
19 . Vein compliance: a preoperative indicator of vein morphology and of veins at risk of vascular graft stenosis. Br J Surg. 1992;79:1019–21.
20 Unsuspected prexeisting saphenous vein disease: An unrecognized cause of vein bypass failure. J Vasc Surg. 1992;15:102–12.
21 Saphenous vein biopsy: A predictor of vein graft failure. J Vasc Surg. 1993;18:407–15.
22 . Infragenicular in situ vein bypass graft occlusion: a multivariate risk factor analysis. Eur J Vasc Surg. 1993;7:567–71.
23 . Vein factors that affect the outcome of femorodistal bypass. Ann R Coll Surg Engl. 1995;77:63–66.
24 . Vein quality in infrainguinal revascularization: assessment by angioscopy and histology. Ann R Coll Surg Engl. 1998;80:3–15.
25 . Vein morphology and bypass graft stenosis. Br J Surg. 1996;83:1375–79.
26 . Endophlebohypertrophy and phlebosclerosis. III. The left innomate vein and superior vena cava. Angiology. 1953;4:301–11.
27 . The pathogenesis of phlebosclerosis: Its relation to arteriosclerosis. III. Phlebosclerosis of the inferior vena cava. Ann Intern Med. 1960;52:1236–45.
28 . Pathogenesis of phlebosclerosis. I. Phlebosclerosis of the portal vein. AMA. Arch Pathol. 1959;68:180–84.
29 . Venous endothelial changes in therapeutic arteriovenous fistulae. Atherosclerosis. 1998;137:149–56.
30 . The future of saphenous vein as a coronary artery bypass conduit. Eur Heart J. 1989;10:273–80.
31 . Reversed vein graft stenosis: early diagnosis and management. J Vasc Surg. 1992;15:130–41.
32 . Thread like calcifications in mesenteric phlebosclerosis. Abdom Radiol. 2018;43:1504–05.
33 . Chronic ischemic colitis causing stenosis: report of a case. Stomach Intest. 1991;26:455–56.
34 . Right hemicolectomy for mesenteric phlebosclerosis potentially caused by long term use of herbal medicine: A case report and literature review. Int J Surg Case Report. 2016;24:191–94.
35 Morphological features of vasa vasorum in pathologically changed human great saphenous vein and its tributaries. vasa. 2008;37:127–36.
36 . Morphology of phlebosclerosis. Wien Med Wochenschr. 1968;118:103–10.
37 . Intimal fibrosis (phlebosclerosis) in the saphenous vein of the lower limb: a quantitative analysis. Virchows Archiv A Pathol Anat. 1992;421:127–31.
38 . The morphofunctional changes in the wall of varicose veins. Ann Vasc Surg. 2017;42:274–84.
39 . Kinetics of vein graft hyperplasia: association with tangential stress. J Vasc Surg. 1987;5:126–36.
40 . Molecular mechanisms in intimal hyperplasia. J Pathol. 2000;190:300–09.
41 . Divergent regulation by growth factors and cytokines of 95- kDa and 72-kDa gelatinases and tissue inhibitors of metalloproteinases- 1, -2 and -3 in rabbit aortic smooth muscle cells. Biochem J. 1996;315:335–42.
42 . Activation of monocyte macrophage functions related to acute atheroma complication by ligation of CD40. Induction of collagenase, stromelysin, and tissue factor. Circulation. 1997;96:393–99.
43 . Expression of vascular adhesion molecules in saphenous vein coronary bypass grafts. Ann Thorac Surg. 1998;65:1685–89.
44 . The cell biology of atherosclerosis, new developments. Aust N Z J Med. 1997;27:497–500.
45 . Distribution and clinical impact of phlebosclerosis. Int Angiol. 2011;30:212–20.
46 . Pathogenesis of primary varicose veins. Br J Surg. 2009;96:1231–42.
47 . Immunocytochemical characterization of the inflammatory cell infiltrate of varicose veins. Eur J Vasc Endovasc Surg. 2004;479–83.
48 . Venous thrombosis – associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. Arterioscler Thromb Vasc Biol. 1995;15:258–68.
49 . The relationship between inflammation and venous thrombosis. A systemic review of clinical studies. Thromb Haemost. 2005;94:362–65.
50 . Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study. J Thromb Haemost. 2004;2:619–22.
51 . Vein wall remodeling in patients with acute deep vein thrombosis and chronic post thrombotic changes. J Thromb Haemost. 2017;15(10):1989–93.
52 Post thrombotic vein wall remodeling: Preliminary observations. J Vasc Surg. 2011;53:139–46.
53 Differential MMP-2 activity of ligament cells under mechanical stretch injury: an in vitro study on human ACL and MCL fibroblasts. J Orthop Res. 2005;23:949–57.
54 Effect of mechanical stretch on HIF-1falphag and MMP-2 expression in capillaries isolated from overloaded skeletal muscles: laser capture microdissection study. Am J Physiol Heart Circ Physiol. 2005;289:1315–20.
55 . New advances in the understanding of the pathophysiology of chronic venous insufficiency. Angiology. 2001;52:27–34.
56 . Calcified and ossified phlebosclerosis. Vasa. 1992;21:11–14.
57 . Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol. 2006;26:1423–30.
58 . The vascular biology of calcification. Semin Dial. 2007;20:103–109.
59 . Idiopathic great saphenous phlebosclerosis. Acta Med Iran. 2013;51:425–26.
60 Arm vein as an alternative autogenous conduit for infragenicular bypass in the treatment of critical limb ischaemia: a 15 year experience. Eur J Vasc Endovasc Surg. 2014;47:609–14.
61 Infrapopliteal-lower extremity revascularization with prosthetic conduit: a 20-year experience. Vasc Endovascular Surg. 2002;36:255–62.
62 Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg. 1986;3:104–11.
63 Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: Results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol. 2004;44:2149–56.
64 . Radial Artery Patency Study Investigators. A randomized comparison of radial-artery and saphenous-vein coronary bypass grafts. N Engl J Med. 2004;351:2302–09.
65 . Serial angiographic follow-up of grafts one year and five years after coronary artery bypass surgery. Eur J Cardiothorac Surg. 2006;29:511–16.
66 . Long-term results of coronary bypass surgery. Ann Surg. 1991;213:377–85.
67 . Infrainguinal vein graft stenosis. Br J Surg. 1993;80:825–33.
68 . Infrainguinal open reconstruction: a review of surgical considerations and expected outcomesVasc Health Risk MANAG. 2017;13:161–68.
69 . Coronary vein graft disease: Pathogenesis and prevention. Can J Cardiol. 2009;25:57–62.
70 Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV. Circulation. 2014;130:1445–51.
71 . Improved results with femoro-popliteal vein grafts for limb salvage. Arch Surg. 1977;112:567–70.
72 . Technical defects as a cause of early graft failure after femoro-distal bypass. Arch Surg. 1987;122:599–604.
73 . Failure of autogenous reversed saphenous vein femoropopliteal grafting: pathophysiology and prevention. Surgery. 1982;91:352–58.
74 . A review of the histological change in vein with particular reference to intimal hyperplasia. Arch Surg. 1988;123:691–96.
